CORRELATION OF NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH LIPOPROTEIN(A) IN DIABETIC PATIENTS

Authors

  • Vasanthan M Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute, Kattankulathur, Kanchipuram, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i9.26278

Keywords:

Lipoprotein(a), Non-high-density lipoprotein, Coronary artery disease

Abstract

Objective: The objective of this study is to estimate the level of lipoprotein(a) and lipid profile, especially non-high-density lipoprotein cholesterol (non-HDL-C) in diabetic patients, and to correlate the same with healthy controls (non-diabetics).

Methods: A total of 30 non-diabetic subjects and 30 diabetic patients were included in the study. Lipoprotein(a) (Lp[a]) was estimated by immunoturbidimetry and the other parameters by their respective methods in biochemistry auto-analyzer.

Result: From the study, it was found that both Lp(a) and non-HDLC were increased in diabetics when compared to the non-diabetic controls. It was also evident that there is a positive correlation of Lp(a) levels with non-HDL C.

Conclusion: Lp(a) and non-HDL C are responsible for atherogenic events in uncontrolled diabetic patients, leading to risks such as coronary artery disease.

Downloads

Download data is not yet available.

References

Kumpatla S, Soni A, Narasingan SN, Viswanathan V. Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C - A report from South India. Indian Heart J 2016;68:378-9.

Berg K. A new serum type system in man – The Lp system. Acta Pathol Microbiol Scand 1963;59:369-82.

Mbewu AD, Durrington PN. Lipoprotein (a): Structure and possible involvement in thrombogenesis and atherosclerosis. Atherosclerosis 1999;85:1-14.

Kamstrip PR, Nordestgard BG. Extreme lipoprotein(a) levels and myocardial infarction. Circulation 2008;117:176-84.

Salonen EM, Jauhiainen M, Zardi L, Vaheri A, Ehnholm C. Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it. EMBO J 1989;8:4035-40.

Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: Current status. Eur Heart J 2010;31:2844-53.

Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG. Lipoprotein(a) and risk of myocardial infarction – genetic epidemiologic evidence of causality. Scand J Clin Lab Invest 2011;71:87-93.

Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000;102:1082-5.

Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke: A meta-analysis of observational studies. Stroke 2007;38:1959-66.

Schreiner PJ, Morrisett JD, Sharrett AR, Patsch W, Tyroler HA, Wu K, et al. Lipoprotein[a] as a risk factor for preclinical atherosclerosis. Arterioscler Thromb 1993;13:826-33.

Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohta T, Yamashita S, et al. Proposed guidelines for hypertriglyceridemia in japan with non-HDL cholesterol as the second target. J Atheroscler Thromb 2008;15:116-21.

Frontini MG, Srinivasan SR, Xu J, Tang R, Bond MG, Berenson GS. Usefulness of childhood non–high-density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: The Bogalusa heart study. Pediatrics 2008;121:24-9.

Kawamoto R, Oka Y, Tomita H, Kodama A. Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly. J Atheroscler Thromb 2005;12:143-8.

Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009;202:289-95.

Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM, et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005;28:1916-21.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005;112:3375-83.

Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB, et al. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 2007;48:2499 505.

Butt M, Ali AM, Bakry MM. Lipid profile patterns and association between glycated hemoglobin (HbA1C) and atherogenic index of plasma (AIP) in diabetes patients at a tertiary care hospital in Malaysia. Int J Pharm Pharm Sci 2017;9:150-4.

Nayak BS, Bhaktha G. Inconsistent lipid profiles exhibited among the diabetic Asian Indians of India and Trinidad–a comparative study. Int J Pharm Pharm Sci 2016;8:60-3.

Published

07-09-2018

How to Cite

M, V. “CORRELATION OF NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH LIPOPROTEIN(A) IN DIABETIC PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 9, Sept. 2018, pp. 499-01, doi:10.22159/ajpcr.2018.v11i9.26278.

Issue

Section

Original Article(s)